‘Global Bioactive Wound Care Market Worth $8,052m In 2021’ Says Visiongain Report
28 August 2018
Visiongain’s new report Global Bioactive Wound Care Market Forecasts 2017-2027: Biological Wound Care, Moist Wound Care and Antimicrobial Wound Care indicates that the global bioactive wound care market will see $8,052m in spending in 2021.
The global bioactive wound care market is expected to grow at a CAGR of 8.7% in the first half of the forecast period and CAGR of 7.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 8.0% from 2017 to 2027. The market is estimated at $4,825 million in 2016, $8,052 million in 2021, and $12,420 million in 2027.
The lead analyst of the report said: “The bioactive wound care market is set to experience considerable growth over the next decade. The main drivers for the growth include an increasingly aging population, rising prevalence of diabetes and obesity, and growing patient awareness. In the case of patients suffering from chronic wounds, wound care has become a necessity in order to reduce the risk to one’s life. The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year. The rising incidence provides an avenue for substantial growth in the bioactive wound care market over the coming years.”
The 213-page report contains 100 tables and 103 figures that add visual analysis in order to explain the developing trends within the Global Bioactive Wound Care Market. Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments of this market: Biological Wound Care, Moist Wound Care, and Antimicrobial Wound Care.
The 213-page report offers market forecasts for the US, Canada, Germany, UK, Spain, Italy, France, Russia, Poland, Japan, China, India, South Korea, Australia, New Zealand, Brazil, Mexico, Turkey, Saudi Arabia, Israel and South Africa. In addition, the report contains a dedicated leading companies’ chapter covering companies leading the field in the bioactive wound care market.
The report Global Bioactive Wound Care Market Forecasts 2017-2027: Biological Wound Care, Moist Wound Care and Antimicrobial Wound Care report will be of value to anyone who wants to better understand the bioactive wound care market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the bioactive wound care industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033